HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Clinical trials for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation technique tested to improve stem cell transplants for tough blood cancers
Disease control TerminatedThis early-stage study aims to find the safest and most effective dose of a targeted radiation treatment, given with chemotherapy, to prepare patients for a donor stem cell transplant. It is for people with high-risk forms of acute leukemia or myelodysplastic syndrome who are not…
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug combo aims to keep blood cancer at bay after transplant
Disease control OngoingThis study is testing whether adding the immunotherapy drug elotuzumab to standard maintenance therapy (lenalidomide) helps keep multiple myeloma from returning after a patient's own stem cell transplant. The trial involves 113 patients who have recently undergone transplant for …
Matched conditions: HEMATOPOIETIC CELL TRANSPLANTATION RECIPIENT
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC